Skip to content
Ravi Tiku’s Perspective: Decoding Today’s Headlines

Ravi Tiku’s Perspective: Decoding Today’s Headlines

The news tells you what happened. We decode why it matters.

  • Home
  • World
  • America
  • Business
  • Technology
  • Health
  • Life
  • Entertainment
  • Ravi’s Perspective

Eli Lilly

Eli Lilly Hits $1 Trillion Market Value With Strong Stock Rally

November 23, 2025
Eli Lilly Hits $1 Trillion Market Value With Strong Stock Rally

Eli Lilly Stock Joins the $1 Trillion Club as LLY Hits New All-Time Highs Eli Lilly became the first U.S. health care company to reach a $1 trillion market value on November 21, 2025. …

Read more

Categories Finance News Tags Eli Lilly, Market cap, Mounjaro, TrumpRx, Zepbound Leave a comment

“Forget Mounjaro: Zepbound is Eli Lilly’s New Blockbuster Taking Over the Weight Loss Market”

August 20, 2024
"Forget Mounjaro: Zepbound is Eli Lilly's New Blockbuster Taking Over the Weight Loss Market"

Forget Mounjaro: Eli Lilly’s Next Big Blockbuster Has Arrived | The Motley Fool Eli Lilly has just introduced its next major blockbuster drug, Zepbound, and it’s making waves in the pharmaceutical industry. On Sunday, …

Read more

Categories Ravi Speaks Tags blockbuster drug, Eli Lilly, Obesity treatment, weight loss drug, Zepbound Leave a comment

“New Study Reveals Tirzepatide’s Impact on Blood Pressure: A Game-Changer for Obesity Management?”

February 7, 2024
"New Study Reveals Tirzepatide's Impact on Blood Pressure: A Game-Changer for Obesity Management?"

The Impact of Tirzepatide on Blood Pressure: A Breakthrough in Obesity and Diabetes Treatment The article discusses a recent study indicating significant reductions in blood pressure among overweight and obese patients taking the diabetes …

Read more

Categories Must See Tags Blood Pressure Reduction, Eli Lilly, Health research, Obesity management, Tirzepatide Leave a comment

“FDA Approves Eli Lilly’s Zepbound: A Game-Changer in Weight Management”

November 9, 2023
"FDA Approves Eli Lilly's Zepbound: A Game-Changer in Weight Management"

FDA approves Eli Lilly’s tirzepatide for weight loss | Fox Business The FDA has granted approval for Eli Lilly’s type 2 diabetes drug, tirzepatide, for use in chronic weight management. This approval formalizes the …

Read more

Categories Must See Tags Eli Lilly, FDA approval, healthcare advancements, weight management, Zepbound Leave a comment
✔ VERIFIED EXPERT
Ravi Tiku – Professional Sales Expert
Ravi Tiku
Professional Sales Expert
38+ Years | Ex-NSM (Multinational Pharma)
🏅 Gold Medalist   |   📘 Author
🏢 Pharma Leadership
Real-world sales and strategy insights shaped by four decades of leadership.
Meet Ravi Tiku →
📩 Join Ravi Tiku's Perspective
Loading
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Get New Articles by Email

Get Ravi Tiku’s latest articles and perspectives delivered directly to your inbox.

Those who aspire for sales-career.

📚 Books, Gadgets & More

Explore useful products for everyday life on Amazon.

Books, electronics and lifestyle products on Amazon
📚 Books 💻 Electronics 🏠 Home & Living 🌿 Health
🛒 Visit Amazon →

As an Amazon Associate I earn from qualifying purchases.

🌤️ TODAY'S WEATHER
Gurugram, India
Loading today's weather...
☀️ °C
High: °C Low: °C

  • facebook
  • x
  • instagram
  • linkedin
  • pinterest
  • Home
  • About us
  • CALCULATOR
  • Contact
  • Disclaimer
  • Web stories
  • Privacy Policy
  • All-purpose Calculator
  • Get Expert Insights
  • Subscribe
© 2026 Ravi Tiku’s Perspective: Decoding Today’s Headlines • Built with GeneratePress